Medical Board of California Advises Licensees of New Prescribing and Reporting Rules for Controlled Substances Effective January 1, 2021

By Jonathan Padua On October 2, 2020, the Medical Board of California (MBC) issued a notice to its licensees reminding them about two new requirements, effective January 1, 2021, regarding prescribing and reporting on controlled substances. With respect to prescribing, Continue reading

AB 890 Allows Nurse Practitioners to Expand Their Scope of Practice Despite Medical Board of California’s Opposition

By Ellen Williams AB 890 (Wood), as amended August 28, 2020, amends sections 650.01, 805, and 805.5 of, and adds Article 8.5 (commencing with section 2837.100) to the Business and Professions Code to authorize a two-tiered framework for certified nurse Continue reading

Medical Board of California Endorses Legislation Allowing Pharmacists to Administer Potential COVID-19 Vaccines Without Federal-Level Approval

By Jonathan Padua At its August 13, 2020 meeting, the Medical Board of California (MBC), in anticipation of a potential COVID-19 vaccine becoming available to the general public, voted to support AB 1710 (Wood) (Chapter 123, September 24, 2020) a Continue reading